Access to Prescription Digital Therapeutics Act of 2023

Senate Bill 723 - Access to Prescription Digital Therapeutics Act of 2023: Overview, Status, and Impact

Hozzl · 2024-03-12T02:10:52Z

Explore the details of Senate Bill 723 Access to Prescription Digital Therapeutics Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/12/2024, 2:10 AM

Congressional Summary of S 723

Access to Prescription Digital Therapeutics Act of 2023

This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 723

Bill S 723 is currently in the status of Bill Introduced since March 8, 2023. Bill S 723 was introduced during Congress 118 and was introduced to the Senate on March 8, 2023. Bill S 723's most recent activity was Read twice and referred to the Committee on Finance. as of March 8, 2023

Bipartisan Support of Bill S 723

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 723

Primary Policy Focus

Health

Potential Impact Areas

- Business records

- Civil actions and liability

- Computers and information technology

- Digital media

- Health care costs and insurance

- Internet, web applications, social media

- Medicaid

- Medicare

- Prescription drugs

Alternate Title(s) of Bill S 723

Access to Prescription Digital Therapeutics Act of 2023

A bill to amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes.